SOX2 and hepatocellular carcinoma: With increasing substrate stiffness, HCC cells exhibited a higher proportion of cells expressing CD133(+)/EpCAM(+), alongside with elevated expression levels of CD133, EpCAM, Nanog, and SOX2, indicating a link between stiffness and key signaling pathways involved in cell growth and survival.